AOD9604 in Intra-Articular Cartilage Research In a 32-rabbit controlled study, weekly intra-articular injections of AOD9604 at 0.25 mg were evaluated over 47 weeks in a collagenase-induced osteoarthritis model
While the GH increase from CJC-1295/Ipamorelin is more modest than pharmaceutical GH replacement, it operates through the same pathway and avoids the side effect profile associated with exogenous GH administration
It helps improve nerve function, relieve numbness, tingling, and weakness, and supports overall nerve health
somatropin (not sermorelin) is the standard FDA-approved therapy for confirmed deficiency
In controlled studies, GHK-Cu has been shown to increase follicle size, extend the anagen (growth) phase, and improve overall hair density
If these appear, reduce tirzepatide dose, pause 5-amino-1MQ, and increase caloric intake by 200400 kcal daily until symptoms resolve